Company intelligence / Profile preview

Starpax Biopharma Inc.

Montréal, Quebec/QC, Canadastarpaxbiopharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Starpax’s preclinical studies have shown a reported “100% remission rate” with no significant side effects across all tested subjects. The technology delivers drugs directly into solid tumors—including hard-to-reach hypoxic zones—using self-propelled Magnetodrones™, guided and contained by the PolarTrak® device. This approach aims to overcome major limitations of traditional systemic therapies by maximizing tumor drug exposure while minimizing systemic toxicity. Clinical trials are set to begin in six solid tumor indications targeting unmet medical needs.[4][6]

Therapeutic areas: Oncology
Modalities: Drug delivery (via Magnetodrones™)Localized chemotherapy[6]Immunotherapy[6]Medical device-assisted therapy (PolarTrak®)[1][4][6]
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

sn-38

Pre-clinical

Indications: Rectal cancer, Pancreatic cancer, Head and neck cancer, Breast cancer metastasis, Vulvar cancer, Prostate cancer

Beyond the preview

Go deeper on Starpax Biopharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Starpax Biopharma Inc..

Explore the full profile